Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2257 - 2264 of 11456 results
How the FTC’s Health Breach Notification Rule Will Impact Health Apps
October 5, 2021| News
Cybersecurity and ERISA Fiduciary Responsibilities for Retirement Plans
October 5, 2021| News
NY Hero Act Update: Activated Plans Must Remain in Place until October 31, 2021
October 5, 2021| Blog| Viewpoint
California Legislature Passes New Key Privacy Laws, Expected to Be Signed Next Week
October 4, 2021| Blog| Viewpoint
Optis Puts Apple’s Feet to the UK Fire: Commit to FRAND or Be Snuffed Out
October 4, 2021| Blog| Viewpoint
Coverage of FDA’s AI/ML Medical Devices Workshop - Part 1: The History of FDA Software Regulation
October 4, 2021| Blog| Viewpoint
FTC Promises More Rigorous Merger Reviews
October 1, 2021| Alert| Viewpoint
PTAB “Overlooks” Rehearing Consequences and Swings the Rehearing Door Wide Open
October 1, 2021| Blog| Viewpoint
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Defending AI, Machine Learning Patents In Life Sciences
October 1, 2024
Intellectual Property Chair Michael Renaud and Associates Meena Seralathan, Simone Yhap, and Williams Dixon recently wrote an article for Law360 focused on protecting artificial intelligence and machine learning patents in the life sciences industry following the US Supreme Court’s 2014 decision in Alice v. CLS Bank.